C-ISLE: Grazoprevir/Elbasvir plus Sofosbuvir in Treatment-naive and Treatment-experienced HCV GT3 Cirrhotic Patients Treated for 8, 12 or 16 weeks

Volume
64
Pagination
39A - 40A
ISSN
0270-9139
Metadata
Show full item record
Authors
Foster, GR; Agarwal, K; Cramp, M; Moreea, S; Barclay, ST; Collier, J; Brown, AS; Ryder, SD; Ustianowski, A; Forton, DM
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/19346
Collections
Copyright statements
Copyright © 2016 American Association for the Study of Liver Diseases.